India takes its first step towards opening door to Controlled Human Infection Studies
1 year, 4 months ago

India takes its first step towards opening door to Controlled Human Infection Studies

The Hindu  

India has taken its first step to introduce Controlled Human Infection Studies, used in many countries for vaccine and treatment development. “This paper is aimed at addressing a variety of ethical issues so that research can be conducted in India without compromising on ethical principles while ensuring the protection of human participants,” notes ICMR. ICMR notes that India has so far stayed away from CHIS, because regardless of the potential scientific benefits, these studies are ethically sensitive and raise concerns about contentious research ethics — issues like deliberate harm, possible disproportionate payment and hence inducements, third-party risk, withdrawal from the study and research with vulnerable participants. CHIS is a relatively new research model that helps provide unique insights into disease pathogenesis and can accelerate the development of novel medical interventions, said ICMR.

History of this topic

Is India ready for Controlled Human Infection Studies? | In Focus podcast
1 year, 3 months ago
Health Matters | In search of freedom from malaise
1 year, 4 months ago
Navigating global governance, national strategies, and ethics in biowarfare
1 year, 4 months ago
Health Matters | Treating diseases — going back to go forward
1 year, 4 months ago
Explained | Are human challenge studies effective?
1 year, 4 months ago
Is India’s health research aligned with India’s health needs?
1 year, 4 months ago
Welcome development: The Hindu Editorial on the ICMR and Controlled Human Infection Studies
1 year, 4 months ago
US eager to involve Indian investigators in clinical trials on COVID-19, says Anthony Fauci
3 years, 6 months ago
‘75% People Must be Immune’: Lessons from Polio, HIV/AIDS Fight as India Readies for Covid Vaccination
3 years, 11 months ago
India must take the lead in devising bio-defences
4 years, 3 months ago
India is a constructive, dependable actor globally, writes Harsh Vardhan Shringla
4 years, 4 months ago
Human Challenge Trial Neither Essential Nor Ethically Justified at This Time, Says US Expert Anthony Fauci
4 years, 4 months ago
Coronavirus | India has key vaccine role: Anthony Fauci
4 years, 4 months ago

Discover Related